Sheri McCoy is former Chief Executive Officer and Director of Avon Products, Inc. Prior to Avon, Ms. McCoy had a distinguished 30-year career at Johnson & Johnson serving as Vice Chairman of the Executive Committee, responsible for the Pharmaceutical and Consumer business segments that represented more than 60 percent of the company’s revenues. Ms. McCoy joined Johnson & Johnson as a scientist in research and development and subsequently managed businesses in every major product sector, including consumer, prescription medicines, and medical devices, where she held roles including Worldwide Chairman, Pharmaceuticals Group and Worldwide Chairman, Surgical Care Group. Ms. McCoy has experience in mergers and acquisitions and management of complex global structures.
In addition to serving as Chairman at Certara, Sheri serves on the boards of AstraZeneca PLC, a global, science-led biopharmaceutical business; Stryker Corporation, a Fortune 500 medical technologies firm; Kimberly-Clark, a multinational personal care corporation; and Novocure, a novel oncology company. She is also an industrial adviser for EQT, in connection with which she chairs Certara and Aldevron, leading supplier of DNA plasmids, and serves as a director at Galderma, a skin health business.
Ms. McCoy holds a Bachelor of Science degree in textile chemistry from the University of Massachusetts, Dartmouth, a Master’s degree in chemical engineering from Princeton University, and an MBA from Rutgers University. She holds four US patents, and she has been on Fortune magazine’s “50 Most Powerful Women in Business” list.